IMP
Process View
positive regulation of cell migration involved in sprouting angiogenesis
Any process that increases the frequency, rate or extent of cell migration involved in sprouting angiogenesis. Cell migration involved in sprouting angiogenesis is the orderly movement of endothelial cells into the extracellular matrix in order to form new blood vessels contributing to the process of sprouting angiogenesis.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "positive regulation of cell migration involved in sprouting angiogenesis"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.999 | ||
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.997 | ||
| PTPN22 | protein tyrosine phosphatase, non-receptor type 22 (lymphoid) | 0.984 | ||
| LCK | lymphocyte-specific protein tyrosine kinase | 0.974 | ||
| NRP1 | neuropilin 1 | 0.968 | ||
| VEGFA | vascular endothelial growth factor A | 0.967 | ||
| CD247 | CD247 molecule | 0.835 | ||
| CD3E | CD3e molecule, epsilon (CD3-TCR complex) | 0.766 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.740 | ||
| MEF2A | myocyte enhancer factor 2A | 0.717 | ||
| LAT | linker for activation of T cells | 0.714 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.636 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.570 | Human | |
| MEF2C | myocyte enhancer factor 2C | 0.479 | ||
| PRKD2 | protein kinase D2 | 0.471 | ||
| PGF | placental growth factor | 0.455 | Human | |
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.439 | ||
| PSEN2 | presenilin 2 (Alzheimer disease 4) | 0.277 | ||
| BCL6 | B-cell CLL/lymphoma 6 | 0.245 | ||
| SH3BP2 | SH3-domain binding protein 2 | 0.196 | ||
| PPARA | peroxisome proliferator-activated receptor alpha | 0.185 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.141 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.124 | Human | |
| HDAC7 | histone deacetylase 7 | 0.114 | ||
| COL4A1 | collagen, type IV, alpha 1 | 0.096 | ||
| PTPN6 | protein tyrosine phosphatase, non-receptor type 6 | 0.096 | ||
| VAV1 | vav 1 guanine nucleotide exchange factor | 0.093 | ||
| WASL | Wiskott-Aldrich syndrome-like | 0.092 | ||
| COL5A1 | collagen, type V, alpha 1 | 0.086 | ||
| COL6A1 | collagen, type VI, alpha 1 | 0.068 | ||
| HDAC3 | histone deacetylase 3 | 0.066 | ||
| PDGFC | platelet derived growth factor C | 0.060 | ||
| HDAC5 | histone deacetylase 5 | 0.059 | Human | |
| PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.058 | ||
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.043 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.043 | ||
| NCOR1 | nuclear receptor corepressor 1 | 0.041 | ||
| STC1 | stanniocalcin 1 | 0.039 | ||
| BLNK | B-cell linker | 0.039 | ||
| GABARAP | GABA(A) receptor-associated protein | 0.036 | ||
| BRAF | v-raf murine sarcoma viral oncogene homolog B1 | 0.035 | ||
| COL1A1 | collagen, type I, alpha 1 | 0.034 | ||
| MIF4GD | MIF4G domain containing | 0.032 | ||
| NCOR2 | nuclear receptor corepressor 2 | 0.031 | ||
| NFIL3 | nuclear factor, interleukin 3 regulated | 0.030 | ||
| MAFF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) | 0.029 | ||
| LDLR | low density lipoprotein receptor | 0.026 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.023 | ||
| RASAL2 | RAS protein activator like 2 | 0.022 | ||
| PGR | progesterone receptor | 0.020 | ||
| PRKCQ | protein kinase C, theta | 0.020 | ||
| FGFR1 | fibroblast growth factor receptor 1 | 0.019 | ||
| FHL2 | four and a half LIM domains 2 | 0.019 | ||
| SKI | v-ski sarcoma viral oncogene homolog (avian) | 0.018 | ||
| TBL1X | transducin (beta)-like 1X-linked | 0.018 | ||
| FCGR2A | Fc fragment of IgG, low affinity IIa, receptor (CD32) | 0.018 | ||
| SH2D2A | SH2 domain containing 2A | 0.017 | ||
| ANKS1A | ankyrin repeat and sterile alpha motif domain containing 1A | 0.017 | ||
| HDAC9 | histone deacetylase 9 | 0.017 | ||
| UBASH3B | ubiquitin associated and SH3 domain containing B | 0.017 | ||
| COL4A2 | collagen, type IV, alpha 2 | 0.017 | ||
| PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 | 0.017 | ||
| COL1A2 | collagen, type I, alpha 2 | 0.017 | ||
| MECP2 | methyl CpG binding protein 2 (Rett syndrome) | 0.016 | ||
| THBS1 | thrombospondin 1 | 0.016 | ||
| MPG | N-methylpurine-DNA glycosylase | 0.016 | ||
| AES | amino-terminal enhancer of split | 0.014 | ||
| BAD | BCL2-associated agonist of cell death | 0.014 | ||
| ARAF | v-raf murine sarcoma 3611 viral oncogene homolog | 0.014 | ||
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.012 | ||
| PCDH9 | protocadherin 9 | 0.012 | ||
| ADAMTS1 | ADAM metallopeptidase with thrombospondin type 1 motif, 1 | 0.011 | ||
| NR4A2 | nuclear receptor subfamily 4, group A, member 2 | 0.011 | ||
| RRBP1 | ribosome binding protein 1 homolog 180kDa (dog) | 0.011 | ||
| DDIT4 | DNA-damage-inducible transcript 4 | 0.011 | ||
| ELK1 | ELK1, member of ETS oncogene family | 0.011 | ||
| L3MBTL2 | l(3)mbt-like 2 (Drosophila) | 0.011 | ||
| SH3BP4 | SH3-domain binding protein 4 | 0.011 | ||
| ARHGEF2 | Rho/Rac guanine nucleotide exchange factor (GEF) 2 | 0.010 | ||
| ANGPT2 | angiopoietin 2 | 0.010 | ||
| EPAS1 | endothelial PAS domain protein 1 | 0.010 | ||
| FGR | Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog | 0.010 |